Showing results (51-60 of 123) with videos related to

Sort By:
Pageof 13
Experientia|April 15, 1987
Prevention of experimental liver metastases by D-galactoseG Uhlenbruck, J Beuth, K Oette, et al.
Zentralblatt Fur Bakteriologie : International Journal of Medical Microbiology|December 1, 1990
Immunomodulation by propionibacteriaW Roszkowski, K Roszkowski, H L Ko, et al.
Zentralblatt Fur Bakteriologie : International Journal of Medical Microbiology|September 1, 1990
Comparative study on the macrolides erythromycin and clarithromycin: antibacterial activity and influence on immune responsesK Roszkowski, J Beuth, H L Ko, et al.
Medical Microbiology and Immunology|January 1, 1985
Antibiotics and immunomodulation: effects of cefotaxime, amikacin, mezlocillin, piperacillin and clindamycinW Roszkowski, H L Ko, K Roszkowski, et al.
Cancer Immunology, Immunotherapy : CII|January 1, 1984
Effects of cefotaxime, clindamycin, mezlocillin, and piperacillin on mouse sarcoma L-1 tumorK Roszkowski, H L Ko, W Roszkowski, et al.
Glycoconjugate Journal|February 1, 1995
Importance of lectins for the prevention of bacterial infections and cancer metastasesJ Beuth, H L Ko, G Pulverer, et al.
Zentralblatt Fur Bakteriologie : International Journal of Medical Microbiology|July 1, 1996
Adhesive properties of P-like fimbriae in Klebsiella-speciesA Przondo-Mordarska, D Smutnicka, H L Ko, et al.
Zentralblatt Fur Bakteriologie : International Journal of Medical Microbiology|November 1, 1990
Type of fimbriation determines adherence of Klebsiella bacteria to human epithelial cellsM Würker, J Beuth, H L Ko, et al.
Zentralblatt Fur Bakteriologie, Mikrobiologie, Und Hygiene. Series A, Medical Microbiology, Infectious Diseases, Virology, Parasitology|November 1, 1988
Granulocyte activating factor released from Propionibacterium acnes. A possible mediator of inflammation in acne vulgarisG Pulverer, W Roszkowski, H J Beuth, et al.
Zentralblatt Fur Bakteriologie : International Journal of Medical Microbiology|August 1, 1990
Behaviour of lymphocyte subsets in response to immunotherapy with Propionibacterium avidum KP-40 in cancer patientsJ Beuth, H L Ko, K M Peters, et al.
Pageof 13